COVID-19 policy recommendations for OUD, pain, harm reduction
The AMA provides policy recommendations to help guide policymakers reduce the stress of patients with an opioid use disorder and pain during the COVID-19 outbreak.
AMA statement on Justice Department settlement with Purdue Pharma
Any settlement should be used exclusively for data collection, research, education, overdose prevention, stigma elimination, and evidence-based treatment.
Physicians’ progress toward ending the nation’s drug overdose and death epidemic
Physicians’ progress toward ending the nation’s drug overdose and death epidemic.
AMA report shows evolving, deadlier overdose epidemic
AMA cites need to remove barriers to evidence-based care for patients with pain or a substance use disorder.
E-prescribing controlled substances: Here’s why the clicks add up
70% of physicians e-prescribe, but only 20% can e-prescribe controlled substances. The AMA is asking EHR vendors for action to help change that.
Opioid epidemic: Huge funding boost needed to close treatment gap
Administrative and insurance barriers continue to block access to treatment, AMA President-elect Susan R. Bailey, MD, tells Congress.
TCPI: Share, Listen, Learn Webinar Series
The AMA's monthly webinars—Share, Listen, Learn—provide instruction on topics to excel in practice transformation.
Membership Moves Medicine™
- Free access to JAMA Network™ and CME
- Save hundreds on insurance
- Fight for physicians and patient rights